Addyi was first authorized through the FDA in August 2015 to deal with hypoactive sexual motivation ailment (HSDD) in premenopausal Women of all ages. Which is just yet another way of claiming it boosts sexual intercourse travel (also known as libido) in Women of all ages which have not arrived at m